scipharmtechinc.

SCIPharmtech,Inc.·2022Revenue:$29.04.Actual·CostOfRevenue:$19.64·GrossProfit:$9.4·OperatingIncome:$3.84·IncomeBeforeTax:$12.52·Net ...,CompanyInformation.SCIPharmtech,Inc.isaTaiwan-basedcompanyprincipallyengagedintheprocessing,manufactureandsalesofActivePharmaceutical ...,SCIPharmtech,Inc.股票代號4119旭富(SCI)統編22662545代表人翁維駿電話:03-3543133傳真:03-3543483桃園市蘆竹區濱海里13鄰海湖北路3...

參考資訊如下
SCI Pharmtech, Inc. Company Profile

SCI Pharmtech, Inc. · 2022 Revenue: $29.04. Actual · Cost Of Revenue: $19.64 · Gross Profit: $9.4 · Operating Income: $3.84 · Income Before Tax: $12.52 · Net ...

4119.TW

Company Information. SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical ...

旭富製藥科技股份有限公司

SCI Pharmtech, Inc. 股票代號4119 旭富(SCI) 統編22662545 代表人翁維駿電話:03-3543133 傳真:03-3543483 桃園市蘆竹區濱海里13鄰海湖北路309巷61號. No.61, Ln. 309 ...

Management Team

Established in 2005, Sunny Pharmtech Inc. (Sunny) focused on the development of 505(b)2 New Drug for cancer supportive care to improve the quality of life ...

Sci Pharmtech Inc

Sci Pharmtech Inc | 31 位LinkedIn 關注者。

SCI Pharmtech, Inc. (4119.TW) Company Profile & Facts

SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and specialty ...

SCI Pharmtech

SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange. Since 1989, SCI has ...

旭富製藥科技股份有限公司｜工作徵才簡介

旭富製藥擁有逾百年歷史之瑞士Siegfried 集團於1987 年在台灣所創設，從事中間體、原料藥及特用化學品之研發、生產及行銷，產品外銷歐、美、日醫藥大廠，品質深受客戶 ...

About SCI Pharmtech, Inc..

SCI Pharmtech Inc, formerly Siegfried Chemicals Inc, is an US FDA and EDQM inspected, ISO 9001/14001/OHSAS 18001certified facilities in Taiwan.